Group 1 - Tecan Group successfully raised CHF 150 million through the issuance of a fixed rate domestic straight bond with a coupon of 0.850% and a duration of 5 years [1][2] - The net proceeds from the bond issuance will be used for general corporate purposes, including the repayment of an outstanding CHF 250 million bond maturing in October 2025 [2] - The bonds were placed with institutional investors and private banks in Switzerland, managed by UBS Investment Bank and Zürcher Kantonalbank, with Bank J. Safra Sarasin as Co-Lead Manager [2] Group 2 - Tecan is a global leader in laboratory automation, improving healthcare innovation from life science to clinical applications [3] - Founded in Switzerland in 1980, Tecan has over 3,000 employees and operates manufacturing, research, and development sites in Europe, North America, and Asia [3] - In 2024, Tecan generated sales of CHF 934 million (USD 1,062 million; EUR 984 million) [3]

The conference call will be audio-webcast with synchronized presentation slides. The webcast and a replay of the webcast will be made available in the "Investor Relations" section of Tecan's website www.tecan.com. About Tecan Tecan (www.tecan.com) improves people's lives and health by empowering customers to scale healthcare innovation globally from life science to the clinic. Tecan is a pioneer and global leader in laboratory automation. As an original equipment manufacturer (OEM), Tecan is also a leader i ...